Literature DB >> 3465433

Role of intracellular calcium ion in human promyelocytic leukemia HL-60 cell differentiation.

T Okazaki, T Mochizuki, M Tashima, H Sawada, H Uchino.   

Abstract

The relationship between calcium ions and the differentiation of human promyelocytic leukemia HL-60 cells was investigated. Proliferation of HL-60 cells incubated in calcium-free medium was inhibited without cell differentiation. On the other hand, incubation with 100 microM verapamil markedly inhibited cell proliferation and caused slight cell differentiation into monocytes. Both calcium-free medium and 100 microM verapamil enhanced HL-60 cell differentiation after treatment with 1 nM 1 alpha,25-dihydroxyvitamin D3, 1 nM beta-all-trans-retinoic acid, or 0.75% dimethyl sulfoxide. However, no enhancement was obtained by treatment with 1 nM 12-O-tetradecanoylphorbol-13-acetate. The free cytosolic calcium concentration was measured by the intracellularly trappable fluorescent calcium indicator, quin 2. The increase of intracellular calcium induced by 250 nM ionomycin was completely blocked by 100 microM verapamil in calcium-free medium, suggesting that the high concentration of verapamil (100 microM) blocks the intracellular calcium mobilization in HL-60 cells. Therefore, the enhancing effect of calcium deprivation or verapamil of HL-60 cell differentiation seemed to be closely related to the inhibition of intracellular calcium mobilization. This speculation is supported by the finding that 50 microM 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate, an intracellular calcium antagonist, also enhanced HL-60 cell differentiation induced by 1 alpha,25-dihydroxyvitamin D3, beta-all-trans-retinoic acid, or dimethyl sulfoxide.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3465433

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Sphinganine potentiation of cellular differentiation induced by various anti-leukemia drugs in human leukemia cell line HL-60.

Authors:  B Y Yung
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

Review 2.  Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation.

Authors:  E Abemayor; N Sidell
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

3.  Digoxin treatment reactivates in vivo radioactive iodide uptake and correlates with favorable clinical outcome in non-medullary thyroid cancer.

Authors:  Thomas Crezee; Marika H Tesselaar; James Nagarajah; Willem E Corver; Johannes Morreau; Catrin Pritchard; Shioko Kimura; Josephina G Kuiper; Ilse van Engen-van Grunsven; Jan W A Smit; Romana T Netea-Maier; Theo S Plantinga
Journal:  Cell Oncol (Dordr)       Date:  2021-02-03       Impact factor: 6.730

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.